Mounjaro 10 mg: a studied dose and the pediatric maximum
The short answer
Mounjaro 10 mg is the fourth of six strengths, available after at least 4 weeks on 7.5 mg when more blood sugar control is needed. The FDA label makes it the maximum dose for pediatric patients, while adults may go on to 15 mg. A fill is four pens for 28 days, and LillyDirect self-pay starts at $499 a month.
Key takeaways
- Mounjaro 10 mg is the maximum dose for pediatric patients, who can be treated from 10 years of age.
- Adults may go on to 12.5 mg after at least 4 more weeks, only if more blood sugar control is needed.
- The label says the KwikPen isn't recommended for self-administration by pediatric patients.
- A year at 10 mg at LillyDirect's self-pay starting price is $6,487.
What the label says about Mounjaro 10 mg
Once weeklyA labelled maintenance doseAt least 28 days before any increase
Maximum dose for pediatric patients 10 years and older.
The maximum dosage of MOUNJARO is: 15 mg injected subcutaneously once weekly in adults. 10 mg injected subcutaneously once weekly in pediatric patients.
Comes as: KwikPen (multi-dose, 4 weekly doses); Multi-dose vial (4 weekly doses); Single-dose pen; Single-dose vial.
FDA label: Revised: 8/2026 (DailyMed version 40)
Mounjaro dose schedule from the label
MounjaroRevised: 8/2026 (DailyMed version 40)
Put it on a calendar with the titration schedule builder. Only your prescriber decides when, and whether, your dose changes.
Supply per fill
| Form | Doses per device | Doses per fill | Days per fill | Fills per year |
|---|---|---|---|---|
| KwikPen (multi-dose, 4 weekly doses) | 4 | 4 | 28 | 13 |
| Multi-dose vial (4 weekly doses) | 4 | 4 | 28 | 13 |
| Single-dose pen | 1 | 4 | 28 | 13 |
| Single-dose vial | 1 | 1 | 7 | 52 |
Track run-out and refill dates with the supply tracker.
Mounjaro 10 mg: every way to pay, cheapest first
This table uses the 10 mg dose. Prices can differ at other doses, so use the cost calculator for yours. Swipe the table sideways to see conditions and sources.
| How you pay | Form | Per fill | Cost per mg | Conditions | Source |
|---|---|---|---|---|---|
| Manufacturer savings card (commercial insurance, drug covered) | Single-dose pen | $25 | $0.63 | ConditionsCommercial drug insurance that covers Mounjaro. Pay as little as $25 for a 1-, 2- or 3-month fill; maximum savings $150 per 1-month, $300 per 2-month or $450 per 3-month fill, and $1,950 per calendar year; up to 13 fills per year. Month is 28 days and up to 4 pens. Government beneficiaries excluded. Card expires 12/31/2026. | mounjaro.lilly.com |
| LillyDirect self-pay | Single-dose pen | $499 | $12.48 | ConditionsSelf-pay only through LillyDirect; the same $499/month starting price is shown for every strength (2.5, 5, 7.5, 10, 12.5 and 15 mg). Prescription required; additional taxes and fees may apply; purchase terms apply. | lilly.com |
| Manufacturer savings card (commercial insurance, drug not covered) | Single-dose pen | $499 | $12.48 | ConditionsCommercial drug insurance that does not cover Mounjaro. Pay as low as $499 per 1-month fill (28 days, up to 4 pens); maximum savings $647 per month and $8,411 per calendar year; up to 13 fills per year. Government beneficiaries excluded. Card expires 12/31/2026. | mounjaro.lilly.com |
Savings-card and Medicare prices apply only if you are eligible. "From" prices that telehealth providers advertise are shown only at the lowest strength.
If you miss a dose of Mounjaro
You can move your weekly day, as long as there are at least 3 days between doses.
The day of weekly administration can be changed, if necessary, as long as the time between the two doses is at least 3 days (72 hours).
If it has been more than 4 days, skip it and take your next dose on your usual day.
If more than 4 days have passed, skip the missed dose and administer the next dose on the regularly scheduled day. In each case, patients can then resume their regular once weekly dosing schedule.
If it has been 4 days or less, take it now and carry on with your usual weekly day.
If a dose is missed, instruct patients to administer MOUNJARO as soon as possible within 4 days (96 hours) after the missed dose.
Enter your own dates in the missed-dose helper. If you are unsure, call your prescriber or pharmacist; never take two doses to catch up.
Mounjaro 10 mg means different things depending on who’s taking it. For an adult, it’s the fourth step of six, with two more above. For a pediatric patient (10 years and older), it’s the ceiling.
Two roles on one label
The label’s maximum-dose statement reads: “The maximum dosage of MOUNJARO is: 15 mg injected subcutaneously once weekly in adults. 10 mg injected subcutaneously once weekly in pediatric patients.”
- Adults reach 10 mg from 7.5 mg after at least 4 weeks, and may move on to 12.5 mg after at least 4 more, each time only if additional glycemic control (blood sugar control) is needed.
- Pediatric patients (Mounjaro is approved from 10 years of age) follow the same 2.5 mg increments but stop here. The label says safety and effectiveness have not been established under 10 years of age.
Taking each step at the minimum interval from a 2.5 mg start, 10 mg begins in the thirteenth week. The titration schedule tool works out the dates.
What the label reports at 10 mg
The label’s adult studies of type 2 diabetes tested 10 mg. HbA1c is a blood test that measures average blood sugar. At week 40:
- Monotherapy (Mounjaro on its own): average HbA1c change of -1.7 on 10 mg and -0.1 on placebo (an inactive treatment). Average body-weight change of -7.0 kg and -1.0 kg.
- Added to basal insulin (long-acting insulin): average HbA1c change of -2.4 on 10 mg and -0.9 on placebo.
From the placebo-controlled safety pool: nausea in 15% of people on 10 mg, diarrhea in 13% and decreased appetite in 10%, with 4%, 9% and 1% on placebo. Gastrointestinal (stomach and gut) reactions led 5.4% of people on 10 mg to stop, compared with 0.4% on placebo.
Price and supply at 10 mg
The price doesn’t move at this step or any other. LillyDirect self-pay starts at $499 a month, and a year at 10 mg comes to $6,487. The list price is $1,112.16 per fill.
A fill is one carton of four single-dose 10 mg pens for 28 days. If you stay at 10 mg, as every pediatric patient who reaches it does, that’s 13 cartons a year.
Forms, and a note for younger patients
The label lists 10 mg as a single-dose pen, single-dose vial, multi-dose vial and KwikPen. It adds that the KwikPen isn’t recommended for self-administration by pediatric patients. The prices on this page are for the single-dose pen only.
The Mounjaro cost page covers insurance, Medicare Part D and the savings card. The Mounjaro guide has the full label summary, and the dosing hub compares maximum doses across medicines.
Where to get Mounjaro
1. Manufacturer savings card (commercial insurance, drug covered)
$25 per fill at 10 mg
2. LillyDirect self-pay
$499 per fill at 10 mg
Source: lilly.comGo to the program page
3. Manufacturer savings card (commercial insurance, drug not covered)
$499 per fill at 10 mg
Ranked by cost only. Manufacturer and government programs never pay us. To see every option for your situation, try the cheapest-path quiz.
Frequently asked questions
Is 10 mg the maximum dose of Mounjaro?
For pediatric patients, yes. The label says the maximum dosage is 15 mg once weekly in adults and 10 mg once weekly in pediatric patients. Mounjaro is approved for type 2 diabetes from age 10. An adult on 10 mg may go higher if additional glycemic control is needed. A child or teenager may not.
What did the trials show for Mounjaro 10 mg?
In the 40-week monotherapy trial on the label (Mounjaro on its own), average HbA1c change on 10 mg was -1.7 against -0.1 on placebo, and average body-weight change was -7.0 kg against -1.0 kg. In the 40-week trial added to basal insulin, HbA1c change was -2.4 on 10 mg against -0.9 on placebo.
How much does a year of Mounjaro 10 mg cost?
At LillyDirect's self-pay starting price of $499 a month, a year of 13 fills at 10 mg comes to $6,487. The figure is the same at any strength. With insurance, your yearly cost depends on your plan's copay and on the savings card's caps.
What are the common side effects at Mounjaro 10 mg?
In the label's pooled placebo-controlled trials, people on 10 mg reported nausea (15%, against 4% on placebo), diarrhea (13%, against 9%) and decreased appetite (10%, against 1%). The label reports that 5.4% of people on 10 mg stopped treatment because of gastrointestinal (stomach and gut) reactions, compared with 0.4% on placebo.
Sources (8)
- 1.FDA label (DailyMed): Mounjaro prescribing information, section 14.2, Table 4
“Table 4: Results at Week 40 in a Trial of MOUNJARO as Monotherapy in Adult Patients with Type 2 Diabetes Mellitus with Inadequate Glycemic Control with Diet and Exercise. HbA1c (%) - Change at Week 40: Placebo: -0.1; MOUNJARO 5 mg: -1.8; MOUNJARO 10 mg: -1.7; MOUNJARO 15 mg: -1.7”
- 2.FDA label (DailyMed): Mounjaro prescribing information, section 14.2, Table 4
“Table 4: Results at Week 40 in a Trial of MOUNJARO as Monotherapy in Adult Patients with Type 2 Diabetes Mellitus with Inadequate Glycemic Control with Diet and Exercise. Body Weight (kg) - Change at Week 40: Placebo: -1.0; MOUNJARO 5 mg: -6.3; MOUNJARO 10 mg: -7.0; MOUNJARO 15 mg: -7.8”
- 3.FDA label (DailyMed): Mounjaro prescribing information, section 14.4, Table 8
“Table 8: Results at Week 40 in a Trial of MOUNJARO Added to Basal Insulin with or without Metformin in Adult Patients with Type 2 Diabetes Mellitus. HbA1c (%) - Change at Week 40: Placebo: -0.9; MOUNJARO 5 mg: -2.1; MOUNJARO 10 mg: -2.4; MOUNJARO 15 mg: -2.3”
- 4.FDA label (DailyMed): Mounjaro prescribing information, section 2.2
“MOUNJARO KwikPen is not recommended for self-administration by pediatric patients. MOUNJARO KwikPen is not recommended for self-administration by those who are visually impaired.”
- 5.FDA label (DailyMed): Mounjaro prescribing information, section 8.4
“The safety and effectiveness of MOUNJARO have not been established in pediatric patients less than 10 years of age.”
- 6.
- 7.
- 8.
